CRISPR race: Gene editing’s lower costs, regulations open door to more competition, improved crops

crispr flies from indroso accelerate your research

Monsanto … is investing in gene editing in an effort to keep an edge over rival suppliers of high-tech crop seeds. Monsanto has signed a string of licensing deals to add new gene-editing capabilities to its established methods of genetically modifying seeds, or creating GMOs.

Dr. Robert Fraley, Monsanto’s chief technology officer, said gene editing could help corn plants thrive in dry conditions, or produce tastier bell peppers. “It’s a breakthrough technology,” he said. “It’s going to create just a wave of innovation.”

But startups and established competitors like Dupont and Dow Chemical Co. are also working on gene-edited plants, which can advance through regulatory reviews faster than seeds developed with earlier biotechnology techniques.

…

Gene-edited crops can face looser regulation in the U.S. than crops that have been souped up with outside DNA. Winning world-wide regulatory approval for traditional biotech crops can take 13 years and cost $136 million….

That opens the field to a wider range of competitors, said James Radtke, head of product development for Cibus. “As long as that continues, a company that’s got a smaller budget can actually be a player,” he said.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Next Phase of High-Tech Crops: Editing Their Genes (behind paywall)

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-17-at-1.07.08-PM
'We are dangerously addicted to antidepressants': Should we heed RFK Jr.’s sobering warning?
Screenshot-2026-09-03-at-10.51.20-AM
Viewpoint: Why do online health lies outlive the evidence that debunks them? Read "Everyone Else Is Lying to You"
ChatGPT-Image-Sep-23-2026-01_52_03-PM
Viewpoint: 4 very real AI doomsday scenarios
ChatGPT-Image-Sep-2-2026-02_03_32-PM
How much of a problem is AI’s water use?
ChatGPT-Image-Sep-22-2026-10_32_46-AM
There has been a slew of recent reports of food recalls and foodborne outbreaks. Do we face an escalating problem?
Screenshot-2026-09-23-at-11.55.01-AM
How can we know if social media bans actually help teens?
ChatGPT-Image-Aug-26-2026-12_46_16-PM
Viewpoint: The fake controversy over whether combining childhood vaccines is dangerous— a debate science resolved 25 years ago
Screenshot-2026-09-23-at-3.15.09-PM
Anti-GMO activists in Pakistan rev up their campaign of dire warnings
Screenshot-2026-09-22-at-11.40.28-AM
After Idaho criminalized abortion providers in 2022, one-third of obstetricians fled. Health care advocates are making rural health the case for repealing the ban
Screenshot-2026-09-17-at-12.00.30-PM
Investigative group ProPublica finds links between ectopic pregnancy deaths and abortion bans
Screenshot-2026-09-10-at-12.20.19-PM
'Jet fuel didn't melt the steel': 9/11 conspiracy theories debunked
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.